UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome

Fertility and sterility, 2015-03, Vol.103 (3), p.808-814

2015

Volltextzugriff (PDF)

Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms

Physica medica, 2020-08, Vol.76, p.125-133

2020

Volltextzugriff (PDF)

Limited impact of discretization/interpolation parameters on the predictive power of CT radiomic features in a surgical cohort of pancreatic cancer patients

Radiologia medica, 2023-07, Vol.128 (7), p.799-807

2023

Volltextzugriff (PDF)

Full-Chip Implementation of IDEALSmile on 90-nm-Node Devices by ArF Lithography

Japanese Journal of Applied Physics, 2005-07, Vol.44 (7S), p.5526

2005

Volltextzugriff (PDF)

Virtual Modeling of the Elderly to Improve Health and Wellbeing Status: Experiences in the Active Ageing at Home Project

Ambient Assisted Living, p.71-83

Volltextzugriff (PDF)

Full-chip implementation of IDEALsmile on 90nm node devices with ArF lithography

Digest of Papers. 2004 International Microprocesses and Nanotechnology Conference, 2004, 2004, p.86-86

2004

Volltextzugriff (PDF)

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (7), p.597-609

2020

Volltextzugriff (PDF)

Topological Control in Heterometallic Metal−Organic Frameworks by Anion Templating and Metalloligand Design

Journal of the American Chemical Society, 2006-11, Vol.128 (47), p.15255-15268

2006

Volltextzugriff (PDF)

On the role of team passion in inventing, founding and developing: what happens in the early stages of entrepreneurship?

Journal of small business and enterprise development, 2023-07, Vol.30 (4), p.692-713

2023

Volltextzugriff (PDF)

ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer

Future oncology (London, England), 2022-10, Vol.18 (32), p.3563-3572

2022

Volltextzugriff (PDF)

Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach

Frontiers in oncology, 2021-10, Vol.11, p.704607-704607

2021

Volltextzugriff (PDF)

Pre-symptomatic modified phytohormone profile is associated with lower phytoplasma titres in an Arabidopsis seor1ko line

Scientific reports, 2020-09, Vol.10 (1), p.14770-14770, Article 14770

2020

Volltextzugriff (PDF)

Children with Cerebral Palsy can imagine actions like their normally developed peers

Frontiers in neurology, 2022-09, Vol.13, p.951152-951152

2022

Volltextzugriff (PDF)

The children of dialysis: live-born babies from on-dialysis mothers in Italy--an epidemiological perspective comparing dialysis, kidney transplantation and the overall population

Nephrology, dialysis, transplantation, 2014-08, Vol.29 (8), p.1578-1586

2014

Volltextzugriff (PDF)

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial

Nature medicine, 2024-06, Vol.30 (8), p.2208-2215

2024

Volltextzugriff (PDF)

Rock fines breakage by flow-induced stresses against drag: geo-energy applications

Geomechanics and geophysics for geo-energy and geo-resources., 2024-12, Vol.10 (1), p.1-28, Article 89

2024

Volltextzugriff (PDF)

Abstract OT-28-01: HER2CLIMB-02: A randomized, double-blind, phase 3 study of tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-28-01-OT-28-01

2021

Volltextzugriff (PDF)

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231178125-17588359231178125

2023

Volltextzugriff (PDF)

Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis

PloS one, 2019, Vol.14 (12), p.e0226615

2019

Volltextzugriff (PDF)

Clinical Study and Serological Diagnosis of Vector-Borne Pathogens in Sardinian Dogs

Veterinary sciences, 2024-07, Vol.11 (7), p.313

2024

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(94)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(51)
Humans
(34)
Female
(21)
Oncology
(21)
Male
(16)
Middle Aged
(13)
Aged
(12)
Adult
(11)
Radiology, Nuclear Medicine & Medical Imaging
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Breast Cancer
(7)
Medicine
(7)
Medicine & Public Health
(7)
Survival
(7)
Breast Neoplasms - Pathology
(6)
Metastasis
(6)
Patients
(6)
Physical Sciences
(6)
Retrospective Studies
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome

Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms

Limited impact of discretization/interpolation parameters on the predictive power of CT radiomic features in a surgical cohort of pancreatic cancer patients

Full-Chip Implementation of IDEALSmile on 90-nm-Node Devices by ArF Lithography

Virtual Modeling of the Elderly to Improve Health and Wellbeing Status: Experiences in the Active Ageing at Home Project

Full-chip implementation of IDEALsmile on 90nm node devices with ArF lithography

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Topological Control in Heterometallic Metal−Organic Frameworks by Anion Templating and Metalloligand Design

Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation

On the role of team passion in inventing, founding and developing: what happens in the early stages of entrepreneurship?

ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer

Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach

Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial

Pre-symptomatic modified phytohormone profile is associated with lower phytoplasma titres in an Arabidopsis seor1ko line

Children with Cerebral Palsy can imagine actions like their normally developed peers

The children of dialysis: live-born babies from on-dialysis mothers in Italy--an epidemiological perspective comparing dialysis, kidney transplantation and the overall population

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial

Rock fines breakage by flow-induced stresses against drag: geo-energy applications

Abstract OT-28-01: HER2CLIMB-02: A randomized, double-blind, phase 3 study of tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer

Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis

Clinical Study and Serological Diagnosis of Vector-Borne Pathogens in Sardinian Dogs

Suchergebnisse filtern